All Pharma News
Novartis Kesimpta® Data Shows Long-Term Benefits in MS

Novartis Kesimpta® Data Shows Long-Term Benefits in MS
PR NEWSWIRE
17 Apr 2024
Share Share
Novartis touts trial win, nabs priority review for Fabhalta

Novartis touts trial win, nabs priority review for Fabhalta
Eric Sagonowsky FIERCE PHARMA
15 Apr 2024
Share Share
Novartis Fabhalta® Reduces IgAN Proteinuria By 38.3% Vs Placebo

Novartis Fabhalta® Reduces IgAN Proteinuria By 38.3% Vs Placebo
GLOBENEWSWIRE
15 Apr 2024
Share Share
Novartis pays $150M for Arvinas` prostate tumor protein degrader

Novartis pays $150M for Arvinas` prostate tumor protein degrader
Nick Paul Taylor FIERCE BIOTECH
12 Apr 2024
Share Share
MorphoSys Boards Recommend Accepting Novartis Takeover Offer

MorphoSys Boards Recommend Accepting Novartis Takeover Offer
BUSINESSWIRE
11 Apr 2024
Share Share
Novartis tender offer for MorphoSys AG commences

Novartis tender offer for MorphoSys AG commences
GLOBENEWSWIRE
11 Apr 2024
Share Share
Novartis begins tender offer for MorphoSys

Novartis begins tender offer for MorphoSys
REUTERS
11 Apr 2024
Share Share
Novartis pauses enrollment for Kisqali breast cancer trials to align with nitrosamine guidelines

Novartis pauses enrollment for Kisqali breast cancer trials to align with nitrosamine guidelines
PRESS RELEASE
11 Apr 2024
Share Share
Novartis to cut 680 jobs in product development

Novartis to cut 680 jobs in product development
REUTERS
10 Apr 2024
Share Share
Novartis, Sanofi & PhRMA push FDA on how to better handle complex trial designs

Novartis, Sanofi & PhRMA push FDA on how to better handle complex trial designs
Lia DeGroot ENDPTS
09 Apr 2024
Share Share